1239880-00-2 Usage
General Description
6-Bromoimidazo[1,5-a]pyridine is a chemical compound with the molecular formula C7H5BrN2. It is a heterocyclic organic compound that contains both imidazole and pyridine rings. 6-bromoimidazo[1,5-a]pyridine is often used as a building block in the synthesis of pharmaceuticals and agrochemicals. Its versatile nature and high reactivity make it a valuable tool in organic synthesis, particularly in the creation of new drug compounds and fine chemicals. Its unique structure and potential for diverse functionalization make it an important molecule in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1239880-00-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,8,8 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1239880-00:
(9*1)+(8*2)+(7*3)+(6*9)+(5*8)+(4*8)+(3*0)+(2*0)+(1*0)=172
172 % 10 = 2
So 1239880-00-2 is a valid CAS Registry Number.
1239880-00-2Relevant articles and documents
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
-
, (2019/09/30)
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF
-
Page/Page column 114, (2010/08/18)
Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.
